Items Tagged ‘CD-19’

October 27th, 2014

CD19-Directed CAR T Cells Effective in Management of Relapsed/Refractory Acute Lymphoblastic Leukemia


In a study recently published in The New England Journal of Medicine, doctors have reported achieving sustained remissions in children and adults with relapsed/refractory acute lymphoblastic leukemia (ALL) using CD19-targeted chimeric antigen receptor (CAR)-modified T cells. Acute lymphoblastic lymphoma (ALL) is a fast-growing cancer of the white blood cells. Relapsed/refractory ALL in adults has a […]

View full entry

Tags: Acute Lymphoblastic Leukemia, all, CAR T, CD-19, Leukemia, News